Meet the Fellows Video Series

Meet the talented individuals who were awarded clinical and research fellowship funding from the Neuromuscular Disease Network for Canada (NMD4C), Muscular Dystrophy Canada (MDC), and the Canadian Society of Clinical Neurophysiologists (CSCN)!

 

The NMD4C and MDC are excited to share a new videos series featuring the five incredible fellows: Drs. Emanuela Pannia, Rebecca Robertson, Collin Luk, Marianne Nury and Alasdair Rathbone, recipients of the Neuromuscular Clinical and Research fellowship funding in 2022. Learn more about them as individuals, how they first became involved with NMD research, the people and experiences that have made a significant impact on their career, a piece of advice they would give others considering a career in NMD research, what excites them about their work, how they see their field advancing and ways we can better support patients.

In the second video of the Meet The Fellows video series we hear from Dr. Pannia, Dr. Robertson, Dr. Luk, Dr. Rathbone, and Dr. Nury on the people and experiences that have had a significant impact on their career. They also share their top piece of advice for anyone considering a career in neuromuscular disorder research or care.

Video #1 – Introduction


 

Video #2 – Who are the people and what are the experiences that have had a significant impact on their career?


Video #3 – What Excites You the Most About Your Work?


Thank you to the incredible donors and supporters who have made the funding of these five incredible individuals possible. We look forward to learning more about them as the series unfolds.

Meet the Fellows - now live

Read next...

AGAMREE (vamorolone) Approved treatment for DMD in Canada

A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada

Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.

Website - SBMA published on CMAJ.png

New Best Practice Recommendations for SBMA Care in Canada

Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!

2025 NMD4C ANNUAL MEETING

Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting

On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.

2025 Clinical Summer School

NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders

On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.

2026 Neuromuscular Postdoc Research Fellowship Competition

2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!

Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)

Clinical Fellowship Awardees

Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients

We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.